[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@SomwerIndaMid Somewhere In The Mid
Somewhere In The Mid posts on X about $biib, $lly, $pmn, $pfe the most. They currently have XXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXX +71%
- X Months XXXXX -XX%
- X Year XXXXXX +121%
Mentions: X #
Followers: XXX #
- X Week XXX +0.67%
- X Months XXX +15%
- X Year XXX -XXXX%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence stocks finance cryptocurrencies exchanges
Social topic influence $biib, $lly, $pmn, $pfe, $abos, $axsm, $acad, jnj, $jnj, market cap
Top assets mentioned Biogen Inc (BIIB) Eli Lilly and Company (LLY) Pfizer, Inc. (PFE) Axsome Therapeutics, Inc (AXSM) Acadia Pharmaceuticals Inc. (ACAD) Johnson & Johnson (JNJ) Vertex Protocol (VRTX) Regeneron Pharmaceuticals Inc (REGN) Summit Therapeutics Inc. Common Stock (SMMT) Stellar (XLM)
Top Social Posts #
Top posts by engagements in the last XX hours
"If you care about Alzheimer's and potential investment opportunities this is worth a good listen. $PMN Promis Neurosciences (Nasdaq) $BIIB $PFE $ABOS $LLY $AXSM $AVXL $SAVA $RHHBY $ACAD $IKT"
@SomwerIndaMid on X 2025-06-29 18:54:22 UTC XXX followers, XX engagements
""As of July XX 2025 the Company had NOT observed any cases of amyloid-related imaging abnormalities (ARIA) including brain swelling or microhemorrhages during the trial." #AlzheimersDisease #PMN310 $PMN $BIIB $PFE $LLY $ABOS $JNJ $ALEC $ANNX $ACAD" @SomwerIndaMid on X 2025-07-26 03:52:16 UTC XXX followers, XXX engagements
"A lot of hypesters getting in on the $PMN bandwagon due to PPS movements. Read the backstory and invest based on scientific quality market cap vs market opportunity and clinical results- not hype. #PMN310 $BIIB $LLY $PFE $JNJ #pharma #stocks" @SomwerIndaMid on X 2025-07-26 00:00:02 UTC XXX followers, XXX engagements
"@alzassociation On July XX 2025 the Company announced that the FDA granted Fast Track Designation to PMN310 for the treatment of Alzheimers disease. Company had not observed any cases of amyloid-related imaging abnormalities (ARIA) including brain swelling or microhemorrhages. $BIIB $LLY" @SomwerIndaMid on X 2025-07-26 15:24:13 UTC XXX followers, XX engagements
"@AnalystKane916 long time coming on this one. might be epic if data keeps heading in a good direction. $BIIB market cap used to move $B's per day on good developments when aducanumab was making it through milestones. $PMN PMN310 could be a safer and better alternative with low market cap" @SomwerIndaMid on X 2025-07-25 23:55:23 UTC XXX followers, XX engagements
"On July XX Thomas Shrader from BTIG maintained a Buy rating on ProMIS Neurosciences $PMN with a price target of $XXXX. Current price: $XXXX $BIIB $AXSM $BNTX $REGN $SMMT $VRTX $PFE $LLY" @SomwerIndaMid on X 2025-07-26 01:08:36 UTC XXX followers, XXX engagements
"@alzassociation A safer tool on the horizon PMN310 just got FDA fast track and initial clinical data shows no ARIA (brain bleed). still a ways to go in clinical trials but safety looks promising so far" @SomwerIndaMid on X 2025-07-26 15:21:50 UTC XXX followers, X engagements